Search and Browse
Download
Enter Data
BDBM30771 2-amino-1-(3-morpholinopropyl)-N-piperonyl-pyrrolo[3,2-b]quinoxaline-3-carboxamide::2-amino-N-(1,3-benzodioxol-5-ylmethyl)-1-(3-morpholin-4-ylpropyl)pyrrolo[3,2-b]quinoxaline-3-carboxamide::2-amino-N-(1,3-benzodioxol-5-ylmethyl)-1-[3-(4-morpholinyl)propyl]-3-pyrrolo[3,2-b]quinoxalinecarboxamide::2-azanyl-N-(1,3-benzodioxol-5-ylmethyl)-1-(3-morpholin-4-ylpropyl)pyrrolo[3,2-b]quinoxaline-3-carboxamide::MLS000040782::SMR000044765::cid_663945
SMILES: Nc1c(C(=O)NCc2ccc3OCOc3c2)c2nc3ccccc3nc2n1CCCN1CCOCC1
InChI Key: InChIKey=NRVYOMDZKFIHNC-UHFFFAOYSA-N
| Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5-hydroxytryptamine receptor 1A (Human) | BDBM30771![]() (2-amino-N-(1,3-benzodioxol-5-ylmethyl)-1-(3-morpho...) | GoogleScholar | UniChem | n/a | n/a | n/a | n/a | 1.10E+4 | n/a | n/a | 7.4 | 23 | |
TBA | Citation and Details | ||||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Sphingosine 1-phosphate receptor 3 (Human) | BDBM30771![]() (2-amino-N-(1,3-benzodioxol-5-ylmethyl)-1-(3-morpho...) | GoogleScholar | UniChem | n/a | n/a | n/a | n/a | 1.91E+4 | n/a | n/a | n/a | n/a | |
TBA | Citation and Details | ||||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Apoptotic protease-activating factor 1 (Human) | BDBM30771![]() (2-amino-N-(1,3-benzodioxol-5-ylmethyl)-1-(3-morpho...) | GoogleScholar | UniChem | n/a | n/a | 7.68E+4 | n/a | n/a | n/a | n/a | n/a | n/a | |
TBA | Citation and Details | ||||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Apoptotic protease-activating factor 1 (Human) | BDBM30771![]() (2-amino-N-(1,3-benzodioxol-5-ylmethyl)-1-(3-morpho...) | GoogleScholar | UniChem | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a | |
TBA | Citation and Details | ||||||||||||
| More data for this Ligand-Target Pair | |||||||||||||